Target Name: OR2W6P
NCBI ID: G81406
Review Report on OR2W6P Target / Biomarker Content of Review Report on OR2W6P Target / Biomarker
OR2W6P
Other Name(s): Olfactory receptor, family 2, subfamily W, member 7 pseudogene | Seven transmembrane helix receptor | Olfactory receptor family 2 subfamily W member 6 pseudogene | olfactory receptor family 2 subfamily W member 6 pseudogene | OR2W7P

OR2W6P: A Potential Drug Target and Biomarker

OR2W6P, a member of the Olfactory receptor family 2, is a pseudogene that encodes for a protein known as OR2W6P. OR2W6P is expressed in the olfactory system, which is responsible for the sense of smell in humans. The olfactory system is composed of the sense of smell and the olfactory neurons, which are responsible for transmitting the sense of smell to the brain.

OR2W6P is a 194 amino acid long protein that is expressed in the olfactory system of humans. It is a member of the Olfactory receptor family 2, which is responsible for the sense of smell. The Olfactory receptor family 2 consists of four genes, OR2A, OR2B, OR2C, and OR2W6P. OR2W6P is the third gene in the family.

OR2W6P is a pseudogene, which means that it is a non-coding gene that encodes for a protein. Pseudogenes are genomic regions that do not code for any functional RNA or protein. OR2W6P is a pseudogene because it is not expressed in the olfactory system. However, it is possible that OR2W6P may be expressed in other tissues and cells.

The lack of expression in the olfactory system makes OR2W6P a potential drug target or biomarker. drugs targeting OR2W6P may be useful in treating conditions that are related to the sense of smell, such as loss of smell, olfactory deficits, and odor disorders.

OR2W6P is also a potential biomarker for certain diseases. For example, it may be used as a diagnostic marker for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. These conditions are characterized by the progressive loss of cognitive and motor function, and they are often associated with the dysfunction of the olfactory system.

In addition to its potential drug and biomarker applications, OR2W6P is also of interest as a potential research tool. The Olfactory receptor family 2 is a well-established model system for understanding the molecular biology of the sense of smell. By studying the function of OR2W6P and the other genes in the Olfactory receptor family 2, researchers may be able to gain insights into the molecular mechanisms of the sense of smell.

OR2W6P is also of interest as a potential therapeutic target for certain diseases. For example, it may be used to treat conditions that are related to the dysfunction of the olfactory system, such as loss of smell and olfactory defects. Additionally, OR2W6P may also be used to treat other diseases that are characterized by the progressive loss of cognitive and motor function, such as Alzheimer's disease and Parkinson's disease.

In conclusion, OR2W6P is a pseudogene that encodes for a protein known as OR2W6P. OR2W6P is expressed in the olfactory system, but it is not expressed in other tissues and cells. Its lack of expression in the olfactory system makes it a potential drug target or biomarker, and its potential use as a therapeutic target for certain diseases makes it a promising research tool. Further research is needed to fully understand the role of OR2W6P in the sense of smell and its potential as a drug and biomarker.

Protein Name: Olfactory Receptor Family 2 Subfamily W Member 6 Pseudogene

Functions: Odorant receptor

The "OR2W6P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR2W6P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

OR2Y1 | OR2Z1 | OR3A1 | OR3A2 | OR3A3 | OR3A4P | OR4A14P | OR4A15 | OR4A16 | OR4A17P | OR4A21P | OR4A47 | OR4A5 | OR4B1 | OR4C11 | OR4C12 | OR4C13 | OR4C15 | OR4C16 | OR4C1P | OR4C3 | OR4C45 | OR4C46 | OR4C5 | OR4C50P | OR4C6 | OR4D1 | OR4D10 | OR4D11 | OR4D2 | OR4D5 | OR4D6 | OR4D9 | OR4E2 | OR4F13P | OR4F15 | OR4F16 | OR4F17 | OR4F21 | OR4F29 | OR4F3 | OR4F4 | OR4F5 | OR4F6 | OR4G3P | OR4K1 | OR4K13 | OR4K14 | OR4K15 | OR4K17 | OR4K2 | OR4K5 | OR4K6P | OR4K7P | OR4L1 | OR4M1 | OR4M2 | OR4M2-OT1 | OR4N2 | OR4N3P | OR4N4 | OR4N5 | OR4P4 | OR4Q3 | OR4S1 | OR4S2 | OR4T1P | OR4V1P | OR4X1 | OR4X2 | OR51A1P | OR51A2 | OR51A3P | OR51A4 | OR51A6P | OR51A7 | OR51B2 | OR51B4 | OR51B5 | OR51B6 | OR51C1P | OR51D1 | OR51E1 | OR51E2 | OR51F1 | OR51F2 | OR51G1 | OR51G2 | OR51H1 | OR51I1 | OR51I2 | OR51J1 | OR51L1 | OR51M1 | OR51Q1 | OR51S1 | OR51T1 | OR51V1 | OR52A1 | OR52A4P